Your SlideShare is downloading. ×
0
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Community Clinical Oncology Program (CCOP)
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Community Clinical Oncology Program (CCOP)

209

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
209
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Community ClinicalCommunity Clinical Oncology Program (CCOP)Oncology Program (CCOP) CCOP RFACCOP RFA Minority Based CCOP RFAMinority Based CCOP RFA Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research Group, DCP, NCI, NIH, DHHS
  • 2. CCOP Network: Goal is to access to state of the art cancer care by linking community hospitals & physicians to NCI designated Cooperative Groups & Centers. Purpose is to accrue patients and at risk people to NCI approved treatment and cancer control clinical trials (prevention, symptom management, etc) Community Clinical Oncology Program
  • 3. FY 2009 Funded CCOP Grants  47 CCOPS (28 States)  14 MB-CCOPS (11 States & Puerto Rico)  12 Research Bases  3,405 Participating Physicians  2,190 Physicians Accrue Trial Participants  1,215 Physicians Refer Trial Participants  395 Participating Hospitals Community Clinical Oncology Program
  • 4. June 2009
  • 5. 0 1 2 3 4 5 6 7 8 9 1995 1997 1999 2001 2003 2005 2007 Thousand Treatment Accr Prev & Control Accr Community Clinical Oncology Program
  • 6. Impact on Cancer Research Since 1983  235,528 Patients on NCI Clinical Trials  139,275 Patients on Treatment Trials  96,253 Patients/Those at Risk for Cancer on Prevention and Control Trials Community Clinical Oncology Program
  • 7. Previous Evaluations:  1984 Initial Evaluation: Could they accrue? Quality of Care  1988 Follow Up: Quality of Data, Cancer Control  1991 MB-CCOP: Increase Minority Accrual  2003 CCOP Follow Up  2005 MB-CCOP Follow Up  2007 R01 Diffusion/Dissemination  2009 R01 Supplement for Business Case Successful Infrastructure to Bring the Science to the Community Evaluation History
  • 8.  CCOP & MB-CCOP Programs Successfully Met and Exceeded Their Major Goals  Knowledge Gained from CCOP & MB-CCOP Investigators is Disseminated Throughout the Medical Community & Integrated into Practice  Demonstrated Capacity to Engage CCOP & MB-CCOP in Cancer Prevention & Control Research and Enhancing the Clinical Trial Infrastructure  Uniquely Positive Impact on NCI Mission of Training, Collaboration, Community Involvement, & Translating Research Results External Review Panel Evaluation
  • 9. Strategic Planning Process  Align the Infrastructure & Incentives with Changing Nature of Clinical Trials  Include Physicians, Administrators from CCOPs, MB- CCOPs and Research Base Investigators & External Experts  Develop Short & Long-term Goals Community Clinical Oncology Program External Review Panel Recommendations
  • 10. Strategic Planning Process  Relationship with Other Programs:  Efforts to Engage Other PBRNs  HMO Network  Dental PBRNs & ONJ Study  Minority Populations:  Eligibility Criteria for MB-CCOPs Community Clinical Oncology Program External Review Panel Recommendations
  • 11.  Expand Program Goals to Improve Efficiency, Productivity, & Collaboration in Design & Conduct of Clinical Trials  Community Physicians Sit on All Disease Steering Committees & Operational Efficiency Working Group  Symptom Management QOL Steering Committee  Recognize Unique Needs to Expand Program Goals Community Clinical Oncology Program External Review Panel Recommendations
  • 12. Community Clinical Oncology Program External Review Panel Recommendations  Metrics Beyond Accrual  Accrual AND Data Quality Primary Metric of Performance  Consider Other Metrics to Include  Patients Screened for Complex Studies  Collection of Biospecimens in Conjunction with Studies  Operational Efficiency Metrics

×